hi all

here is a partial listing of the articles referring to parkinson
added to PubMed in the past 30 days; which puts my current research
'barometer' reading at 137

if you want to look at the abstract of one of these
enter the PMID number into the search window at the PubMed site at:
http://www.ncbi.nlm.nih.gov/PubMed/

if you want to look at the full article,
the medical journal may be available on line through PubMed;
otherwise, try your favourite medical library
(or your favourite neurologist's waiting room!)

i used to try to post all of the pubmed abstracts dealing with parkinsons
so as to get them all into our list archives,
(instead of just the titles, which this posting achieves)
but
the volume got too heavy!
but
i'm not complaining!

janet

--------------------------------------------------------------------
Human and Mouse alpha-Synuclein Genes: Comparative Genomic Sequence
Analysis and Identification of a Novel Gene Regulatory Element.
PMID: 11156617

A neural model of working memory processes in normal subjects, Parkinson's
disease and schizophrenia for fMRI design and predictions.
PMID: 11156204; UI: 21027899

Timed tests in the clinical assessment of motor function in Parkinson's
disease.
PMID: 11155348; UI: 21028444

Postural instability in Parkinson's disease: a comparison with and without
a concurrent task.
PMID: 11154931

Nicotinamide-N-methyltransferase is higher in the lumbar cerebrospinal
fluid of patients with Parkinson's disease.
PMID: 11154840

Nonlinear analysis of brain activity in magnetic influenced Parkinson
patients.
PMID: 11154103; UI: 21026994

Visual hallucinations induced by deep brain stimulation in Parkinson's
disease.
PMID: 11154099; UI: 21026988

Adverse drug reactions to selegiline: a review of the French
pharmacovigilance database.
PMID: 11154095; UI: 21026984

A comparison of dopamine agonists and catechol-O-methyltransferase
inhibitors in Parkinson's disease.
PMID: 11154093; UI: 21026982

Parkinson's disease therapy: tailoring choices for early and late disease,
young and old patients.
PMID: 11154092; UI: 21026981

Nonparkinsonian tremors.
PMID: 11154090; UI: 21026979

Causes of death in a community-based study of Parkinson's disease.
PMID: 11153892; UI: 21026748

The psychological refractory period in Parkinson's disease.
PMID: 11153866; UI: 21026727

CB1 Cannabinoid Receptor Inhibits Synaptic Release of Glutamate in Rat
Dorsolateral Striatum.
PMID: 11152748

Dopamine D-1/D-5 Receptor Activation Is Required for Long-Term Potentiation
in the Rat Neostriatum In Vitro.
PMID: 11152712

Evidence for a Partially-Folded Intermediate in {alpha}-Synuclein Fibril
Formation.
PMID: 11152691

Levodopa, bromocriptine and selegiline modify cardiovascular responses in
Parkinson's disease.
PMID: 11151420; UI: 21025896

Is clonidine growth hormone stimulation a good test to differentiate
multiple system atrophy from idiopathic Parkinson's disease?
PMID: 11151417; UI: 21025893

One Further Case of Pancytopenia Induced by Olanzapine in a Parkinson's
Disease Patient.
PMID: 11150845

Nicotine prevents striatal dopamine loss produced by 6-hydroxydopamine
lesion in the substantia nigra(1).
PMID: 11150495

Melatonin protects against 6-OHDA-induced neurotoxicity in rats: a role for
mitochondrial complex I activity.
PMID: 11149904

Too many treatments for Parkinson's disease: another look.
PMID: 11149259; UI: 21025100

Too many treatments for Parkinson's disease: another look.
PMID: 11149258; UI: 21025099

Single or continuous injection of glial cell line-derived neurotrophic
factor in the striatum induces recovery of the nigrostriatal dopaminergic
system.
PMID: 11149247; UI: 21025095

Pesticides and parkinsonism: is there an etiological link?
PMID: 11148671; UI: 21025168

OLFACTION.
PMID: 11148312

Competency to consent to medical treatment in cognitively impaired patients
with Parkinson's disease.
PMID: 11148230

Relationship of substantia nigra echogenicity and motor function in elderly
subjects.
PMID: 11148229

Welding-related parkinsonism: Clinical features, treatment, and
pathophysiology.
PMID: 11148228

Environmental toxins accelerate Parkinson's disease onset.
PMID: 11148226

Pallidotomy for parkinson disease: a review of contemporary literature.
PMID: 11147896; UI: 21023396

Pulsatile stimulation of dopamine receptors and levodopa-induced motor
complications in Parkinson's disease: implications for the early use of
COMT inhibitors.
PMID: 11147513; UI: 21023050

The place of COMT inhibitors in the armamentarium of drugs for the
treatment of Parkinson's disease.
PMID: 11147512; UI: 21023049

Practical issues with COMT inhibitors in Parkinson's disease.
PMID: 11147511; UI: 21023048

Issues important for rational COMT inhibition.
PMID: 11147507; UI: 21023044

Levodopa in the treatment of Parkinson's disease.
PMID: 11147506; UI: 21023042

The evolution and origin of motor complications in Parkinson's disease.
PMID: 11147505; UI: 21023043

Imaging of dopamine transporters with technetium-99m TRODAT-1 and single
photon emission computed tomography.
PMID: 11147397; UI: 21000520

Ascorbic acid increases the yield of dopaminergic neurons derived from
basic fibroblast growth factor expanded mesencephalic precursors.
PMID: 11146004

Mitochondria deficient in complex I activity are depolarized by hydrogen
peroxide in nerve terminals: relevance to Parkinson's disease.
PMID: 11146003

N-Acetyl-L-cysteine protects SHSY5Y neuroblastoma cells from oxidative
stress and cell cytotoxicity: effects on ss-amyloid secretion and tau
phosphorylation.
PMID: 11145996

The solubility of alpha-synuclein in multiple system atrophy differs from
that of dementia with Lewy bodies and Parkinson's disease.
PMID: 11145981

Parkinson's disease and impaired chemosensitivity to hypoxia.
PMID: 11145519; UI: 21017735

Parkinson's disease and impaired chemosensitivity to hypoxia.
PMID: 11145518; UI: 21017734

An open-label, multicentre clinical trial to determine the levodopa
dose-sparing capacity of pramipexole in patients with idiopathic
Parkinson's disease.
PMID: 11145006; UI: 21017668

Amantadine infusion in treatment of motor fluctuations and dyskinesias in
Parkinson's disease.
PMID: 11145005; UI: 21017667

FDG- and Dopa-PET in postencephalitic parkinsonism.
PMID: 11145004; UI: 21017666

Grafting of encapsulated dopamine-secreting cells in Parkinson's disease:
long-term primate study.
PMID: 11144970; UI: 21017689

Behavioral evaluation of hemiparkinsonian MPTP monkeys following dopamine
pharmacological manipulation and adrenal co-graft transplantation.
PMID: 11144958; UI: 21017677

Grafting of nigral tissue hibernated with tirilazad mesylate and glial cell
line-derived neurotrophic factor.
PMID: 11144955; UI: 21017674

The localization and functional contribution of striatal aromatic L-amino
acid decarboxylase to L-3,4-dihydroxyphenylalanine decarboxylation in
rodent parkinsonian models.
PMID: 11144954; UI: 21017673

Gamma knife thalamotomy for treatment of tremor: long-term results.
PMID: 11143229; UI: 21004889

Evaluation of gamma thalamotomy for parkinsonian and other tremors:
survival of neurons adjacent to the thalamic lesion after gamma thalamotomy.
PMID: 11143228; UI: 21004888

Judgment of disability stages in Parkinson disease patients due to
pathological tremor of index finger.
PMID: 11142111; UI: 21022900

Restoration of function by neural transplantation in the ischemic brain.
PMID: 11142041; UI: 21022830

Neuropathology of fetal nigra transplants for Parkinson's disease.
PMID: 11142034; UI: 21022824

Clinical observations after neural transplantation in Parkinson's disease.
PMID: 11142032; UI: 21022822

The primate model of Parkinson's disease: its usefulness, limitations, and
importance in directing future studies.
PMID: 11142031; UI: 21022821

Transplantation in the rat model of Parkinson's disease: ectopic versus
homotopic graft placement.
PMID: 11142030; UI: 21022820

Improving the survival of grafted embryonic dopamine neurons in rodent
models of Parkinson's disease.
PMID: 11142029; UI: 21022819

Neuro-ophthalmology of movement disorders.
PMID: 11141633; UI: 21022382

Hepatic disposition of neurotoxins and pesticides.
PMID: 11140828; UI: 21021100

Therapeutic advances in idiopathic Parkinsonism.
PMID: 11139811

Gene therapy for Parkinson's disease: review and update.
PMID: 11139810

Drosophila models of human neurodegenerative disease.
PMID: 11139281

Dopamine mercapturate can augment dopaminergic neurodegeneration.
PMID: 11139134; UI: 21020082

Resistance training and gait function in patients with Parkinson's disease.
PMID: 11138953; UI: 21019901

CGP 3466 protects dopaminergic neurons in lesion models of Parkinson's
disease.
PMID: 11138845; UI: 21019791

The parkinsonian models: invertebrates to mammals.
PMID: 11138723; UI: 21019669

Parkinson's disease: nuclear medicine in the spotlight.
PMID: 11138674; UI: 21019621

Proteasomal function is impaired in substantia nigra in Parkinson's disease.
PMID: 11137760

Deficits in sensorimotor control during precise hand movements in
Huntington's disease.
PMID: 11137666

Investigation of non-linear properties of multichannel EEG in the early stages
of Parkinson's disease.
PMID: 11137659

Lymphocyte populations in Parkinson's disease and in rat models of
parkinsonism.
PMID: 11137586

Risk factors for hip fracture among elderly patients with Parkinson's disease.
PMID: 11137512

Possible extrapyramidal system degradation in Parkinson's disease.
PMID: 11136999; UI: 20578677

Heart rate variability in patients with untreated Parkinson's disease.
PMID: 11136353; UI: 20577515

Basal ganglia metabolite concentrations in idiopathic Parkinson's disease
and multiple system atrophy measured by proton magnetic resonance
spectroscopy.
PMID: 11136352; UI: 20577514

A two-fold difference in the age-adjusted prevalences of Parkinson's
disease between the island of als and the faroe islands.
PMID: 11136351; UI: 20577513

Role of dopamine D1 and D2 receptors in the micturition reflex in conscious
rats.
PMID: 11135387

Parkinson's disease as multifactorial oxidative neurodegeneration:
implications for integrative management.
PMID: 11134975; UI: 20577592

Parkinson's: better living through chemicals?
PMID: 11134974; UI: 20577591

Time-course and dose-response study on the effects of chronic L-DOPA
administration on striatal dopamine levels and dopamine transporter
following MPTP toxicity.
PMID: 11134595
--------------------------------------------------------------------

janet paterson, an akinetic rigid subtype parkie
53 now / 44 dx cd / 43 onset cd / 41 dx pd / 37 onset pd
TEL: 613 256 8340 SMAIL: PO Box 171 Almonte Ontario K0A 1A0 Canada
EMAIL: [log in to unmask] URL: http://www.geocities.com/janet313/